These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3497889)

  • 21. Prostaglandin E2 inhibits the generation of phytohemagglutinin-activated killer activity in human peripheral blood lymphocytes.
    Yamashita N; Ito M; Suzuki H; Sugiyama E; Yokoyama A; Sato M; Yano S
    Anticancer Res; 1986; 6(5):1113-6. PubMed ID: 3492171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The mechanisms of inhibition of human IL 2 production. II. PGE2 induction of suppressor T lymphocytes.
    Chouaib S; Chatenoud L; Klatzmann D; Fradelizi D
    J Immunol; 1984 Apr; 132(4):1851-7. PubMed ID: 6230395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro inhibition of interleukin-2 production by peripheral blood lymphocytes from stage III melanoma patients by prostaglandin E2: enhancement of lymphocyte proliferation by exogenous interleukin-2 plus indomethacin.
    Murray JL; Dowd J; Hersh EM
    J Biol Response Mod; 1986 Feb; 5(1):12-9. PubMed ID: 3485703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Participation of interleukins in synergistic effect of Bu-WSA on concanavalin A-induced DNA synthesis in mouse splenic lymphocytes.
    Nitta T; Konno-Ejiri H; Nemoto K; Okumura S; Ozawa A; Nakano M
    Scand J Immunol; 1986 Sep; 24(3):297-305. PubMed ID: 3489286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of indomethacin and interleukin-2 on the proliferation of lymphocytes from patients with lung cancer.
    Maca RD; Burford JG; Taylor RT
    J Clin Immunol; 1985 May; 5(3):158-65. PubMed ID: 3874210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of human B cell activation by prostaglandin E2. Suppression of the generation of immunoglobulin-secreting cells.
    Jelinek DF; Thompson PA; Lipsky PE
    J Clin Invest; 1985 Apr; 75(4):1339-49. PubMed ID: 3872889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of immuno-modulating agents on murine IL-2 production.
    Weng XC; Zhang P; Gong SS; Xiai SW
    Immunol Invest; 1987 Apr; 16(2):79-86. PubMed ID: 2957320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipoxygenase specific inhibitors inhibit murine lymphocyte reactivity to Con A by reducing IL-2 production and its action.
    Kato K; Murota S
    Prostaglandins Leukot Med; 1985 Apr; 18(1):39-52. PubMed ID: 3923496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human alveolar macrophages suppress interleukin-1 (IL-1) activity via the secretion of prostaglandin E2.
    Monick M; Glazier J; Hunninghake GW
    Am Rev Respir Dis; 1987 Jan; 135(1):72-7. PubMed ID: 3492161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of prostaglandin E2 and other intracellular cyclic AMP elevating agents on the mitogen induced mouse splenocyte proliferation in a serum free culture condition.
    Zhong WW; Chavali SR; Forse RA
    Life Sci; 1994; 55(11):PL193-8. PubMed ID: 8072381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of prostaglandin E2 on responses of T-cell subsets to mitogen and autologous non-T-cell stimulation.
    Honda M; Steinberg AD
    Clin Immunol Immunopathol; 1984 Oct; 33(1):111-22. PubMed ID: 6236922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human lymphocytes induce a differential release of prostaglandin E2 and interleukin 1-like mononuclear cell factor from normal blood monocytes.
    Roth A; Kaufmann MT; Cruchaud A; Dayer JM
    Eur J Immunol; 1985 Sep; 15(9):960-3. PubMed ID: 2995051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased interleukin-1 and modulation of interleukin-2 production by murine macrophages and lymphocytes treated with LF 1695.
    Pascal M; Derrepas P
    Int J Immunopharmacol; 1986; 8(5):499-508. PubMed ID: 3019905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of thymocyte proliferative response by macrophage-derived prostaglandin E2 and interleukin 1.
    Hayari Y; Kukulansky T; Globerson A
    Eur J Immunol; 1985 Jan; 15(1):43-7. PubMed ID: 2981690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of human B cell proliferation by prostaglandin E2.
    Thompson PA; Jelinek DF; Lipsky PE
    J Immunol; 1984 Nov; 133(5):2446-53. PubMed ID: 6332851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autologous and allogeneic mixed-lymphocyte responses following thermal injury in man: the immunomodulatory effects of interleukin 1, interleukin 2, and a prostaglandin inhibitor, WY-18251.
    Antonacci AC; Calvano SE; Reaves LE; Prajapati A; Bockman R; Welte K; Mertelsmann R; Gupta S; Good RA; Shires GT
    Clin Immunol Immunopathol; 1984 Feb; 30(2):304-20. PubMed ID: 6229378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-4 inhibits prostaglandin G/H synthase-2 and cytosolic phospholipase A2 induction in neonatal mouse parietal bone cultures.
    Kawaguchi H; Nemoto K; Raisz LG; Harrison JR; Voznesensky OS; Alander CB; Pilbeam CC
    J Bone Miner Res; 1996 Mar; 11(3):358-66. PubMed ID: 8852946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of lymphocyte alloreactivity by early gestational human decidua. II. Characterization of the suppressor mechanisms.
    Lala PK; Kennedy TG; Parhar RS
    Cell Immunol; 1988 Oct; 116(2):411-22. PubMed ID: 3263215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of mitogen-induced lymphocyte proliferation by ouabain: interference with interleukin 2 production and interleukin 2 action.
    Stoeck M; Northoff H; Resch K
    J Immunol; 1983 Sep; 131(3):1433-7. PubMed ID: 6604100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The regulation of gamma-interferon production by interleukins 1 and 2.
    Croll AD; Morris AG
    Cell Immunol; 1986 Oct; 102(1):33-42. PubMed ID: 3100055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.